The Kingdom’s pharmaceutical industry is undergoing rapid transformation under Vision 2030, with the market projected to exceed $15 billion
Saudi Arabia’s pharmaceutical sector is undergoing a major strategic transformation as the Kingdom accelerates efforts to strengthen pharmaceutical security, expand local manufacturing, localize advanced technologies, reduce medicine waste and deploy artificial intelligence across supply chains.
Driven by the objectives of Saudi Vision 2030, the strategy aims to build a more resilient pharmaceutical ecosystem capable of securing critical medical supplies, reducing exposure to disruptions in global supply chains and supporting the Kingdom’s broader economic diversification agenda.
Pharmaceutical Market Projected to Exceed $15 Billion
The sector’s growth prospects highlight the scale of emerging investment opportunities.
According to Fitch Solutions estimates cited by Al Arabiya, Saudi Arabia’s pharmaceutical market was valued at approximately $11.72 billion, or around SAR44 billion, in 2022.
The market is projected to reach approximately $15.09 billion, equivalent to about SAR56.6 billion, by 2027, representing a compound annual growth rate of around 5.2 percent.
This expansion is increasing the importance of developing a competitive domestic manufacturing base capable of serving local demand while positioning Saudi pharmaceutical companies to expand into regional and international markets.
Local Manufacturing at the Heart of Pharmaceutical Security
Dr. Yasser Al-Obaida, CEO of Sudair Pharma, said Saudi Arabia has made significant progress in strengthening its pharmaceutical security, particularly following lessons learned during the COVID-19 pandemic.
The pandemic highlighted the strategic importance of domestic manufacturing capacity in maintaining access to essential medicines during global emergencies and supply chain disruptions.
Saudi Arabia is therefore working to increase the local production of essential and strategically important medicines, diversify sources of pharmaceutical raw materials and establish strategic reserves of critical products.
The localization drive is also expanding into sophisticated segments including biologic medicines, oncology treatments, vaccines and plasma-derived products.
Pharmaceutical Factories More Than Double in Five Years
Omar Al-Kharashi, an investor in the pharmaceutical sector and a member of the Industries and Energy Committee at the Riyadh Chamber, highlighted the rapid expansion of Saudi Arabia’s pharmaceutical manufacturing landscape.
According to his comments to Al Arabiya, the number of registered pharmaceutical factories increased from approximately 40 in 2020 to nearly 85 in 2025.
Authorities are also intensifying efforts to attract major international pharmaceutical companies by promoting investment incentives and encouraging global manufacturers to establish production facilities in the Kingdom or form partnerships that facilitate technology and knowledge transfer.
Artificial Intelligence Set to Transform the Industry
Artificial intelligence is expected to become one of the most important technologies reshaping Saudi Arabia’s pharmaceutical sector.
AI-powered systems can help forecast medicine demand using demographic and epidemiological data, manage inventories in real time and generate early warnings when potential shortages or surpluses are detected.
Digital technologies can also improve pharmaceutical traceability throughout the supply chain, from manufacturing facilities to warehouses, hospitals and pharmacies.
These capabilities could support more accurate procurement and distribution decisions while helping manufacturers improve production efficiency and reduce operational waste.
Building an Integrated, Data-Driven Pharmaceutical Ecosystem
Saudi Arabia’s broader digital transformation could ultimately enable the development of an interconnected pharmaceutical ecosystem linking manufacturers, warehouses, hospitals and pharmacies through data-driven platforms.
Such integration could improve demand forecasting, provide greater visibility into national medicine inventories and allow supplies to be redistributed between healthcare facilities before products expire.
The result would be a more responsive pharmaceutical system capable of improving resource utilization while strengthening national preparedness for potential health emergencies.
Reducing Pharmaceutical Waste
Medicine waste remains an important health and economic challenge.
Factors contributing to waste include dispensing quantities that exceed actual patient needs, inefficient inventory management, expired medicines, duplicate prescriptions and poor adherence to treatment plans.
Potential solutions include unified electronic medication records, intelligent inventory management systems, data analytics for demand forecasting and mechanisms that allow pharmaceutical inventories to be redistributed between healthcare facilities before expiration.
Saudi Arabia’s National Unified Procurement Company for Medical Supplies, known as NUPCO, also plays a role in coordinating pharmaceutical requirements and procurement processes, helping reduce surpluses and improve spending efficiency.
Saudi Arabia Eyes Regional Pharmaceutical Leadership
With advanced industrial infrastructure, a strategic logistics position and continued government support, Saudi Arabia is seeking to strengthen its position as a regional hub for pharmaceutical manufacturing and biotechnology.
The strategic objective is not necessarily complete self-sufficiency across every pharmaceutical category, but rather achieving high levels of domestic capacity for priority and strategically important medicines while simultaneously developing a competitive export-oriented industry.
The Kingdom is increasingly moving beyond conventional pharmaceutical manufacturing toward an innovation-driven ecosystem built around research and development, biotechnology, artificial intelligence and advanced manufacturing.
Together, these developments could strengthen Saudi Arabia’s national health security, improve the resilience of pharmaceutical supply chains and support economic diversification, positioning the sector as an increasingly important contributor to the goals of Saudi Vision 2030.
